Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coagulation Assays in the Critically Ill Patient: a New Approach Using the Thrombomodulin-modified Thrombin Generation Assay (TGA-TM)

NCT04356144 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT04356144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04356144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coagulation Assays in the Critically Ill Patient: a New Approach Using the Thrombomodulin-modified Thrombin Generation Assay (TGA-TM)
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Completed
Start date
April 15, 2020
Completion date
February 1, 2021
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coagulation disorder, blood, covid19, critical illness, disseminated intravascular coagulation, sars-cov2, viral infection